Retrospective Study of Bone-TB in Oman: 2002-2019.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: The authors declare they have no conflicts of interest. 9. Arch Bone Jt Surg. 2018 May;6(3):169-175. Hip Surgery in Quiescent or Active Tubercular Hip Arthritis; Is Reactivation Risk Really a Matter. Parsa A(1)(2)(3)(4), Mirzaie M(1)(2)(3)(4), Ebrahimzadeh MH(1)(2)(3)(4), Birjandinejad A(1)(2)(3)(4), Malek A(1)(2)(3)(4), Mousavian A(1)(2)(3)(4). Author information: (1)Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. (2)Community and Preventive Medicine Specialist, Mashhad University of Medical Sciences, Mashhad, Iran. (3)Orthopedic Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. (4)Department of Pediatrics, Mashhad University of Medical Sciences, Mashhad, Iran. About 15 % of all musculoskeletal tuberculosis (TB) have hip involvement. Early anti-tubercular drug therapy and other conservative treatment including short-term traction and mobilization programs could prevent hip joint destruction. Reactivation of TB accounts for a significant of active TB incidence, especially in the developed countries with a low TB prevalence. The risk of TB activation for population with the latent form of disease is about 5-10%. According to the existing literature surgery in tubercular hip arthritis would be safe once sufficient debridement and precise anti tubercular chemotherapy has been done. PMCID: PMC5990708